Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics

Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics

Cancer therapy–related cardiac dysfunction (CTRCD) is one of the most concerning cardiovascular side effects of cancer treatment. Important reviews within the field of cardio-oncology have described various agents to be associated with a high risk of CTRCD, including mitomycin C, ifosfamide, vincris...

Full description

Bibliographic Details
Main Authors: Janine A.M. Kamphuis, MD, Marijke Linschoten, MD, Maarten J. Cramer, MD, PhD, Eelke H. Gort, MD, PhD, Anna van Rhenen, MD, PhD, Folkert W. Asselbergs, MD, PhD, Pieter A. Doevendans, MD, PhD, Arco J. Teske, MD, PhD
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:JACC. CardioOncology
Subjects:
alkylating therapy
cardiomyopathy
heart failure
risk prediction
Online Access:http://www.sciencedirect.com/science/article/pii/S266608731930078X

Internet

http://www.sciencedirect.com/science/article/pii/S266608731930078X

Similar Items